<--- Back to Details
First PageDocument Content
Biochemistry / Laboratory techniques / Polymerase chain reaction / Amplifiers / Hoffmann-La Roche / Select agent / Glyceraldehyde 3-phosphate dehydrogenase / Centers for Disease Control and Prevention / United States Office of Research Integrity / Biology / Science / Molecular biology
Date: 2015-01-05 10:50:25
Biochemistry
Laboratory techniques
Polymerase chain reaction
Amplifiers
Hoffmann-La Roche
Select agent
Glyceraldehyde 3-phosphate dehydrogenase
Centers for Disease Control and Prevention
United States Office of Research Integrity
Biology
Science
Molecular biology

asabaliauskas on DSK5VPTVN1PROD with NOTICES Federal Register / Vol. 79, No[removed]Thursday, September 18, [removed]Notices the Ras-related GTPase gene in lung and breast cancers.’’ Ann Surg Oncol. 14(4):1397–404, 2

Add to Reading List

Source URL: www.selectagents.gov

Download Document from Source Website

File Size: 172,02 KB

Share Document on Facebook

Similar Documents

TAMIFLU - oseltamivir phosphate powder, for suspension TAMIFLU - oseltamivir phosphate capsule Hoffmann-La Roche Inc DESCRIPTION TAMIFLU (oseltamivir phosphate) is available

TAMIFLU - oseltamivir phosphate powder, for suspension TAMIFLU - oseltamivir phosphate capsule Hoffmann-La Roche Inc DESCRIPTION TAMIFLU (oseltamivir phosphate) is available

DocID: 1v09s - View Document

Panel II: SMA Drugs in Development • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Lawrence Charnas, MD, PhD, Sr. Translational Medicine Expert, Musculoskeletal Diseases, Novart

Panel II: SMA Drugs in Development • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Lawrence Charnas, MD, PhD, Sr. Translational Medicine Expert, Musculoskeletal Diseases, Novart

DocID: 1sY97 - View Document

Panel II: SMA Drugs in Development • Jinsy Andrews MD, Director of Clinical Research and Development, Cytokinetics • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Jerry R. Men

Panel II: SMA Drugs in Development • Jinsy Andrews MD, Director of Clinical Research and Development, Cytokinetics • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Jerry R. Men

DocID: 1sY50 - View Document

FERCAP Conference Empowering Stakeholders in Health Research: Towards Developing an Ethics of Accountability and Responsibility Beat Widler, F. Hoffmann-La Roche Bangkok , Thailand

FERCAP Conference Empowering Stakeholders in Health Research: Towards Developing an Ethics of Accountability and Responsibility Beat Widler, F. Hoffmann-La Roche Bangkok , Thailand

DocID: 1sI6G - View Document

orlistat and pcoc orlistat 60 mg studies persistence analysis sibutramine orlistat, clinical studies orlistat, orlistat and gall stones does orlistat work, health problems and orlistat orlistat and appetite. orlistat pre

orlistat and pcoc orlistat 60 mg studies persistence analysis sibutramine orlistat, clinical studies orlistat, orlistat and gall stones does orlistat work, health problems and orlistat orlistat and appetite. orlistat pre

DocID: 1rrCO - View Document